Drugs / l-LV
last change Aug 2020 re-read 2 minutes ago

l-LV

Developed for
rectal cancer

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02280070 Comparator Sep 2013 → Aug 2018 rectal cancer Clinical Research Support Center Kyush Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as l-LV ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280070
Route Intravenous “l-LV (200 mg/m2) is administered by IV infusion drip” NCT02280070